Stingless Bee Honey Mouth Rinse on Gingivitis

March 4, 2026 updated by: Ministry of Higher Education, Malaysia

The Development of Anti-Inflammatory and Natural-based Mouth Rinse From Stingless Bee Honey

The currently used chemical mouth rinse, chlorhexidine, was prescribed widely among dental practitioners for its ability to kill bacteria. However, chlorhexidine prolonged use is limited due to its adverse events such as extrinsic tooth staining, taste disturbance, effects on the oral mucosa such as soreness, irritation, mild desquamation, mucosal ulceration, general burning sensation and calculus formation. Thus, an alternative natural active agent is needed to produce mouth rinse with less side effect but offer similar disease prevention effect. This comprehensive four-phase research initiative aims to advance the development and evaluation of a stingless bee honey mouth rinse, particularly focusing on improved formulation and tested in vitro and clinically. In Phase I and II, the mouth rinse development involve the improved formulation by xylitol addition in the formulation with physicochemical assessment such as shelf-life followed by antimicrobial activities against Staphylococcus aureus and cytotoxicity evaluation against oral keratinocytes. Phase III focuses on clinical trial in a pilot study that will be performed on twenty volunteers divided to two groups; control and test group who will be using mouth rinse as adjunctive periodontal therapy agent (TRL 5). Comparative analyses will assess the adjunctive effect of this stingless bee honey mouth rinse in periodontal therapy. A commercially packaged mouth rinse will be designed and produced in collaboration with Bayu Gagah Marketing and will be given to the public as free samples to obtain feedback and validate its further use in the health industry.

Study Overview

Detailed Description

INTRODUCTION

This innovative project is aimed to produce natural-based mouth rinse that are safe for users with no side effects, as an alternative to current chemical mouth rinse.

The currently used chemical mouth rinse, chlorhexidine, was prescribed widely among dental practitioners for its ability to kill bacteria. However, our mouth was designed naturally to have normal microbiota living in symbiosis and the change of this normal equilibrium resulted in disease such as reduction in nitrate-reducing bacteria responsible for nitric oxide production. Nitric oxide is one of the molecules involved in blood pressure regulation. Besides this, chlorhexidine was associated with adverse events such as extrinsic tooth staining, taste disturbance, effects on the oral mucosa such as soreness, irritation, mild desquamation, mucosal ulceration, general burning sensation and calculus formation.

On the other hand, there was growing evidence on medicinal properties of stingless bee honey (SBH). SBH has a high concentration of trehalulose, antioxidant, flavonoids, phenolic acids, hydroxyl and aromatics. In vitro, SBH has antioxidant activity that are up to 45% higher than those of Apis mellifera honey and have broad-spectrum antibacterial action against Gram-positive and Gram-negative bacteria as well as fungus. Several studies revealed wound healing and anti-inflammatory capabilities of SBH making it as a promising active agent in mouth rinse formulation to combat oral disease.

General objective:

To develop an anti-inflammatory and natural based mouth rinse from stingless bee honey.

Specific objective:

  1. To develop a mouth rinse from mixture of stingless bee honey, xylitol and mint flavor that are stable physicochemically.
  2. To investigate the antimicrobial effect and cytotoxicity of SBH mouth rinse.
  3. To evaluate the prototype clinical effectiveness in a clinical trial.

    Methodology

    Phase I and II involve laboratory study (Objective 1 and 2). Phase III involve clinical trial (Objective 3).

    i. Study design

    - This is a randomized, single-blinded and placebo-controlled clinical pilot study that will be conducted at Faculty of Dentistry, Universiti Sains Islam Malaysia following ethical approval.

    ii. Participants

    - Sample size was estimated from Sharma et al., 2022 to have 20 samples per arm. Data was analysed using G Power version 3 statistical software. The significance value was set at α value 0.05 with 95% power of the study. From the previous journal, the calculated effect size was 2.2. The calculated sample size was 20 per arm after including a 20% dropout rate.

    - Sixty (twenty per group) participants attending dental clinic at the Faculty of Dentistry, USIM will be invited to participate in the study based on inclusion criteria:

    • 18 to 60 years old patients

    • BPE code 2 and/or below

    • Presence of at least 20 natural teeth

    - These are the exclusion criteria:

    • Diabetes mellitus
    • Smoking
    • Mucosal lesion
    • Allergic to honey
    • Physical or mental disabilities

    iii. Randomization Participants will be randomly allocated to Group A, Group B or Group C based on the order of recruitment. Randomisation will be performed using Microsoft Excel softwate (Microsoft®, USA). Predetermined recruitment numbers (1-30) will be randomly allocated into Groups A, B or C using computer-generated random numbers. Participants' assignment and enrolment in the intervention will be performed by a research assistant.

    iv. Blinding This is a single-blinded study in which each participant and clinicians who will perform data collection will be blinded to the treatment assignment.

    v. Mouth rinse preparation Three different mouth rinse formulations will be prepared;

    • Stingless bee honey (SBH) mouth rinse containing stingless bee honey (Bayu Kelulut®; Bayu Gagah Marketing, Kulim, Malaysia) diluted to a concentration of 20%, xylitol and mint flavor,

    • 0.12% chlorhexidine (CHX) (Oradex, Shah Alam, Malaysia) as gold standard

    • 0.9% saline solution as control.

    vi. Intervention

    Before start of study, scaling and polishing will be performed to remove all calculus and plaque. All participants will be given Colgate® regular toothpaste and a Colgate® soft bristled toothbrush to brush twice daily for washout period (two weeks) and to continue the standardised products throughout the course of study. Standardised brushing technique will be demonstrated by the clinician to ensure they understood the brushing instructions. Participants will be instructed not to use any other oral hygiene aid and abstain from any other mouth rinse than those provided for the study.

    After two weeks of washout period, plaque and bleeding scores will be taken by three calibrated clinicians. After recording the plaque and bleeding scores, scaling and prophylaxis will be performed. A bottle of mouth rinse will be prescribed to the patients, in a sealed bottle.

    - Participants will be instructed to rinse 15ml of mouth rinse twice daily (before breakfast and after dinner) for two minutes, for one month. Group A will receive stingless bee honey mouthrinse, Group B will receive chlorhexidine (Oradex, Malaysia) and Group C will receive 0.9% normal saline solution in a sealed and coded bottle.

    After one month, plaque and bleeding scores will be measured again. Patient's acceptance in terms of taste, halitosis and burning sensation will be measured using visual analogue scale.

    vii. Outcome measures

    - Periodontal parameters such as plaque score and bleeding score will be recorded pre- and post-intervention by calibrated examiners.

    Phase IV: Pre-commercialisation.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18 to 60 years old patients
  • BPE code 2 and/or below
  • Presence of at least 20 natural teeth

Exclusion Criteria:

  • Diabetes mellitus
  • Smoking
  • Mucosal lesion
  • Allergic to honey
  • Physical or mental disabilities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stingless bee honey mouth rinse
Stingless Bee Honey mouth rinse formulation that was developed for this study.
this is a mouth rinse with anti-inflammatory effect but also is used for cosmetic purposes to relieve bad mouth odour.
scaling is performed to remove calculus
instruction is given on performing plaque control
Active Comparator: chorhexidine mouth rinse
0.12% Chlorhexidine mouth rinse as gold standard comparison.
this is a mouth rinse with anti-inflammatory effect but also is used for cosmetic purposes to relieve bad mouth odour.
scaling is performed to remove calculus
instruction is given on performing plaque control
Placebo Comparator: normal saline
0.9% Normal saline as control.
this is a mouth rinse with anti-inflammatory effect but also is used for cosmetic purposes to relieve bad mouth odour.
scaling is performed to remove calculus
instruction is given on performing plaque control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
plaque score
Time Frame: one month
Plaque score percentage will be calculated using dicotomous scale (Ainamo and Bay 1975). Presence of plaque will be assessed using periodontal probe and marked '1' while absence of plaque will be marked '0'. The total number of plaque present will be divided by the total number of sites measured and multiply with 100 to get a percentage.
one month
bleeding score
Time Frame: one month
Bleeding score will be measured using dichotomous scale (Ainamo & Bay 1975). A periodontal probe will be used to detect bleeding on probing and '1' will be marked for its presence and '0' will be marked for its absence. The total number of bleeding present will be divided by the total number of sites assessed and multiply with 100 to get a percentage.
one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient acceptance
Time Frame: one month
Patient acceptance on the mouth rinse including taste, halitosis and burning sensation will be assessed using visual analogue scale whereby the scale ranges between '0' to '10'. '0' represents the worst experience while '10' represents best experience.
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Sharma, S., Sogi, G. M., Saini, V., Chakraborty, T., & Sudan, J. (2022). Effect of liquorice (root extract) mouth rinse on dental plaque and gingivitis - A randomized controlled clinical trial. Journal of Indian Society of Periodontology, 26(1), 51-57. https://doi.org/10.4103/jisp.jisp_517_20

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 6, 2026

Primary Completion (Estimated)

July 30, 2027

Study Completion (Estimated)

November 30, 2027

Study Registration Dates

First Submitted

February 26, 2026

First Submitted That Met QC Criteria

March 4, 2026

First Posted (Actual)

March 10, 2026

Study Record Updates

Last Update Posted (Actual)

March 10, 2026

Last Update Submitted That Met QC Criteria

March 4, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingivitis

Clinical Trials on mouth rinse

Subscribe